The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders: a National registry study
Open Access
- 11 October 2023
- journal article
- research article
- Published by Springer Nature in Addiction Science & Clinical Practice
- Vol. 18 (1) , 1-9
Abstract
Background: The time after contact with specialized health services for mental health and substance use is associated with an increased risk of suicide, where temporal aspects of suicide and comorbid mental disorders in patients with substance use disorders could be associated. This study aimed to examine the temporal association between time from last treatment contact to suicide and comorbid mental disorders in patients with substance use disorders. Methods: This study is a historical prospective case series using nationwide registry data. It included 946 individuals registered the year before suicide with a substance use disorder (F10-F19) in Norway's specialized health services for treating substance use and mental health disorders between 2010 and 2020. The outcome was the number of weeks from the last contact with services to suicide. The exposure was comorbid mental disorders divided into 'no comorbid mental disorder’; ‘psychosis or bipolar disorders’ (F20−F31), ‘depressive or anxiety disorders' (F32−F49); and 'personality disorders' (F60-F69). Covariates included gender, age, last diagnosed substance use disorder, registered deliberate self-harm last year, and the number of in- and outpatient contacts the previous year. Results: The number of weeks from last service contact to suicide differed (p = < 0.001) between patients with no comorbid mental disorders (Median = 7; IQR 2–23), psychosis or bipolar disorders (Median = 2; IQR = 1–7), depressive or anxiety disorders (Median = 3; IQR = 1–11) and personality disorders (Median = 1; IQR = 1–5.5). Significantly decreased adjusted incidence rate ratios (aIRR) were found for psychosis or bipolar disorders [aIRR = 0.67 (95% CI 0.53–0.85)] and personality disorders [aIRR = 0.56 (0.42–0.77)] compared to no comorbid mental disorder when adjusted for individual characteristics and service contact. For depressive and anxiety disorders compared to no comorbid mental disorder, the association was significant when adjusted for individual characteristics [aIRR = 0.55 (0.46–0.66)]. Conclusions: While patients with substance use disorders generally died by suicide a short time after contact with services, patients with comorbid mental disorders died an even shorter time after such contact and significantly shorter than patients without such comorbidities.Keywords
Funding Information
- EkstraStiftelsen Helse og Rehabilitering (2021/FO347373)
- University of Oslo
This publication has 27 references indexed in Scilit:
- Suicide Rates After Discharge From Psychiatric FacilitiesJAMA Psychiatry, 2017
- The quality of severe mental disorder diagnoses in a national health registry as compared to research diagnoses based on structured interviewBMC Psychiatry, 2017
- Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation‐wide, prospective, register‐based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorderAddiction, 2017
- Are suicide deaths under-reported? Nationwide re-evaluations of 1800 deaths in ScandinaviaBMJ Open, 2015
- Data quality in the Causes of Death RegistryTidsskrift for Den norske legeforening, 2015
- A record‐linkage study of drug‐related death and suicide after hospital discharge among drug‐treatment clients inScotland, 1996–2006Addiction, 2012
- Safety Planning Intervention: A Brief Intervention to Mitigate Suicide RiskCognitive and Behavioral Practice, 2012
- Implementation of mental health service recommendations in England and Wales and suicide rates, 1997–2006: a cross-sectional and before-and-after observational studyThe Lancet, 2012
- Dual diagnosisAddictive Behaviors, 1998
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987